Cardiac Arrest Is Not a Heart Attack. Neurological Fate Is Determined Within Minutes of Collapse.

What It Is

The Distinction That Matters Before Anything Else

Cardiac arrest and heart attack are not the same event. Clinicians use these terms with precision. Patients and media frequently do not. The confusion is not trivial because it shapes how people understand their risk, their symptoms, and their window to act.

A heart attack (myocardial infarction) is a plumbing problem. A coronary artery, blocked by ruptured atherosclerotic plaque, stops delivering oxygen to a region of heart muscle. The muscle is injured or dying. The heart keeps beating. The patient is usually awake, often in pain, frequently diaphoretic and nauseated. There is time: time to call 911, time to drive to the emergency department, time for the interventional cardiologist to open the artery with a stent.

Cardiac arrest is an electrical problem. The heart’s organized electrical system fails, the muscle stops contracting in a coordinated way, and effective circulation stops within seconds. The patient loses consciousness. Breathing ceases. Death is the default outcome without immediate intervention. There is no time: each minute without CPR reduces survival to hospital discharge by 7 to 10 percent 5 / Solid .

The two can overlap. Roughly 70 percent of out-of-hospital cardiac arrests are caused by coronary artery disease, and many of those are triggered by an acute MI 5 / Solid . But a cardiac arrest is not a heart attack. A patient can have a massive MI and not arrest. A patient can arrest with perfectly clean coronary arteries.

Sudden Cardiac Arrest vs Sudden Cardiac Death

Sudden cardiac arrest (SCA) is the event: the heart stops, the patient collapses. Sudden cardiac death (SCD) is the outcome when resuscitation fails. Every SCD began as an SCA. Not every SCA becomes SCD. The 10 percent national survival rate means roughly 90 percent of SCA events become SCD. That gap is the clinical problem this entire lane of addresses.

The Most Common Underlying Rhythm

When you place defibrillator pads on a patient who has just arrested and look at the rhythm, you most commonly see one of four things:

1. Ventricular fibrillation (VFib): Chaotic, disorganized electrical activity. No meaningful contraction. Defibrillation is effective.
2. Pulseless ventricular tachycardia (pulseless VT): Rapid, organized but hemodynamically inadequate. Defibrillation is effective.
3. Pulseless electrical activity (PEA): Electrical activity present on monitor, no mechanical pulse. Defibrillation is not effective; treatment is finding and reversing the underlying cause.
4. Asystole: No electrical activity. Defibrillation is not effective.

VFib and pulseless VT are “shockable rhythms.” They account for approximately 25 to 30 percent of out-of-hospital cardiac arrests in contemporary registries 5 / Solid . The proportion of shockable rhythms has declined over decades, possibly because more arrests are now witnessed earlier in their evolution before rhythm degenerates, or because underlying disease patterns have shifted.

Shockable rhythms have better survival than PEA or asystole. This is not because VFib is a “better” arrest; it is because we have an effective, immediate treatment for it.

Who Is at Risk

Risk is not uniformly distributed. Five populations carry disproportionate burden:

Prior MI or low ejection fraction. Patients with a left ventricular ejection fraction below 35 percent face an annual sudden death risk of 3 to 5 percent without prophylactic ICD therapy 5 / Solid .

Inherited channelopathies. Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), and hypertrophic cardiomyopathy (HCM) collectively account for a meaningful fraction of SCA in patients under 40 4 / Promising .

Coronary artery disease without prior MI. Severe, unrecognized CAD can present as SCA without any prior cardiac event. This is the patient who “had no history.” The coronary artery calcium (CAC) score identifies this population before the first event.

Structural heart disease. Dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy (ARVC), and hypertensive heart disease all increase SCA risk.

Uncontrolled modifiable risk factors. Uncontrolled hypertension, heavy alcohol use, cocaine use, severe hypokalemia, and QT-prolonging medications each independently increase VFib susceptibility.

The Mechanism

How the Heart’s Electrical System Fails

The normal heartbeat begins at the sinoatrial (SA) node in the right atrium, travels through the atrioventricular (AV) node, splits down the bundle of His into left and right bundle branches, and spreads through the Purkinje fibers to activate the ventricles in a coordinated wave. That wave produces the P-QRS-T you see on an ECG and the mechanical contraction you feel as a pulse.

VFib, the most common shockable arrest rhythm, occurs when this organized wave is replaced by hundreds of simultaneous micro-reentrant circuits, each generating its own chaotic depolarization. The ventricles quiver rather than contract. Cardiac output drops to zero within seconds.

What triggers this? Three mechanisms account for most arrests:

Reentry: Scar tissue from a prior MI creates zones of slow conduction adjacent to normal-conduction tissue. Electrical impulses enter the scar, conduct slowly, exit into normal tissue that has already repolarized, and circulate in a loop. If the loop is fast enough and the vulnerable period of the action potential is hit correctly, the circulating impulse can capture the entire ventricle. This is the mechanism behind post-MI VFib and most sustained VT.

Triggered activity: Early afterdepolarizations (EADs) and delayed afterdepolarizations (DADs) are abnormal secondary depolarizations during or just after repolarization. Long QT syndrome, whether genetic or drug-induced, creates EADs that can degenerate into Torsades de Pointes and then into VFib.

Automaticity: Ischemic myocytes can spontaneously depolarize at high rates. During acute MI, the border zone between ischemic and normal tissue generates ectopic impulses that can initiate VFib.

The Oxygen Debt Begins Immediately

Brain cells begin to die within four to six minutes of zero perfusion. This is not gradual. At the four-minute mark, irreversible neuronal injury begins in the hippocampus and cerebral cortex. By ten minutes without any circulation, the probability of meaningful neurological recovery falls sharply. By fifteen minutes without circulation, it approaches zero.

This timeline is why every minute matters in a way that almost no other medical emergency matches. A patient with a STEMI can tolerate thirty minutes between symptom onset and balloon dilation without catastrophic neurological injury. A patient in VFib cannot.

Why TV Gets This Wrong

Cardiac arrest as depicted in popular media is a calm, organized procedure with a high success rate. The patient lies still. Compressions are light. The defibrillator shock causes a clean convulsion. The patient opens their eyes, grateful and conversational.

The actual experience is nothing like this.

Effective CPR requires compressing the adult sternum 2 to 2.4 inches at 100 to 120 compressions per minute. Done correctly, it is exhausting. It frequently fractures ribs. It does not look peaceful. The patient does not wake up and thank anyone. Most patients who achieve ROSC (return of spontaneous circulation) are intubated and unconscious, transferred to the ICU for post-arrest care, and face days of uncertainty about neurological recovery.

The TV version of cardiac arrest survival contributes to unrealistic patient and family expectations about CPR outcomes in elderly patients with multiple comorbidities, which is a central issue in goals-of-care conversations. That topic is addressed in the DNR and Goals of Care article in this lane.

How We Diagnose It / How It Is Used

Diagnosis in the Field

Cardiac arrest is a clinical diagnosis. It does not require an ECG to start treatment. The diagnostic criteria, as taught in every basic life support course, are two findings:

1. Unresponsiveness
2. Absent or abnormal breathing (gasping, agonal breathing)

The lay rescuer checks for both, then acts. Pulse check is unreliable among lay rescuers 5 / Solid 00927-4), which is why AHA guidelines de-emphasize it for bystanders in favor of immediate CPR when the patient is unresponsive and not breathing normally.

In the hospital, rhythm diagnosis follows immediately: pads are placed, the defibrillator identifies shockable vs non-shockable rhythm, and the ACLS algorithm bifurcates accordingly.

The Survival Chain

The American Heart Association’s “chain of survival” has been the conceptual framework for cardiac arrest systems since the 1990s. For out-of-hospital arrest, the links are:

1. Recognition and activation (calling 911)
2. Immediate high-quality CPR (bystander)
3. Rapid defibrillation (AED)
4. Advanced resuscitation (EMS)
5. Post-arrest care (hospital)
6. Recovery (rehabilitation, lifestyle)

Each link is independently associated with survival. Each link that breaks costs lives.

The CARES (Cardiac Arrest Registry to Enhance Survival) database, which tracks out-of-hospital arrests in the United States, documents that communities with bystander CPR rates above 40 percent achieve significantly better outcomes than communities where bystander CPR is rare 5 / Solid .

What Changes Survival Most

Three interventions account for the largest survival gains, and two of them happen before EMS arrives:

Bystander CPR: The PRIMED trial and subsequent registry analyses confirm that bystander CPR doubles to triples survival compared to no CPR prior to EMS arrival 5 / Solid . Bystander CPR does not restore the heart to normal rhythm. It maintains minimal perfusion to the brain and coronary arteries, buying time for defibrillation.

Public-access defibrillation: The PAD trial demonstrated that when AEDs were placed in public locations and volunteers were trained to use them, survival for cardiac arrest in those locations nearly doubled compared to conventional EMS response 5 / Solid . The denominator is location-specific: airports and casinos have shown high survival rates because AEDs are present, staffed, and used quickly.

High-performance EMS systems: Systems with sub-four-minute first-responder times, compression-fraction targets above 80 percent, and post-arrest protocols achieve survivals that approach 40 percent for witnessed VFib arrests 4 / Promising .

What Does Not Change Survival in Out-of-Hospital Arrest

Several interventions studied in randomized trials have not demonstrated survival benefit:

• Amiodarone vs lidocaine vs placebo in refractory VF/pulseless VT: The ALPS trial (ROC ALPS, Kudenchuk et al., NEJM 2016, 10.1056/NEJMoa1602127) randomized patients with refractory shockable rhythms to amiodarone, lidocaine, or placebo. Both drugs improved survival to hospital admission, but neither improved survival to discharge or neurological recovery.
• Vasopressin added to epinephrine: No survival benefit over epinephrine alone 5 / Solid .
• Epinephrine itself: The PARAMEDIC2 trial (Perkins et al., NEJM 2018, 10.1056/NEJMoa1806842) showed epinephrine improved ROSC and survival to hospital discharge (3.2% vs 2.4%, p=0.02), but more survivors in the epinephrine group had severe neurological impairment (31% vs 17.8% poor neurological outcome among survivors). The drug saves a pulse; it does not always save a brain.

These findings are not nihilistic. They reflect the hard truth that most of what matters in cardiac arrest happens in the first minutes, before any drug reaches the circulation.

The Evidence

Landmark Registries and Trials

The Bystander CPR Effect in Detail

The mechanism is straightforward: CPR delivers approximately 30 percent of normal cardiac output. That minimal perfusion prevents brain death during the several minutes it takes for an AED or EMS to arrive. Every prospective analysis of OHCA outcomes confirms that bystander CPR, even imperfect bystander CPR, improves survival. The Hasselqvist-Ax 2015 NEJM study of the Swedish OHCA registry (n=30,381) found that bystander CPR was associated with a 30-day survival OR of 2.15 (95% CI, 1.88 to 2.45) 5 / Solid .

The size of this effect rivals the survival benefit of ICD therapy in the highest-risk patients. The difference is that ICD therapy requires cardiology evaluation, a procedure, a device, and ongoing monitoring. Bystander CPR requires thirty minutes of training and the willingness to act.

The AED Defibrillation Time Curve

The relationship between time to first shock and survival is linear and steep. Cummins and colleagues established the 7 to 10 percent per minute survival decline decades ago 5 / Solid . Contemporary data from the CARES registry confirm this slope has not changed. At one minute from collapse to shock: survival above 50 percent in witnessed VFib. At ten minutes: survival below 5 percent.

This is why the placement of AEDs in high-density locations, and the training of high-risk households to use them, is a public health intervention with a calculable return.

Why the National Survival Rate Remains at 10 Percent

If the evidence is clear, why does the national survival rate stay around 10 percent? Four structural barriers explain most of the gap:

1. Unwitnessed arrests. Approximately 55 to 60 percent of out-of-hospital arrests are unwitnessed 5 / Solid . No bystander means no CPR, no AED activation, no survival chain.
2. Non-shockable presenting rhythms. PEA and asystole have no effective field treatment beyond CPR and reversible-cause correction. They account for 70 to 75 percent of presenting rhythms and have survival rates below 3 percent.
3. Geographic barriers. Rural America has EMS response times that frequently exceed eight to ten minutes, well beyond the window where first-shock survival is meaningful 4 / Promising .
4. Bystander hesitation. Fear of doing harm, fear of disease transmission, uncertainty about technique. All addressable with training. All common without it.

The Patient Experience

What the Patient’s Family Sees

The patient collapses. They may make a brief cry or grunt, then go limp. Within 30 to 90 seconds, they may begin agonal breathing: gasping, irregular breaths that can look like the person is breathing but are not effective. This is frequently misidentified as normal breathing by untrained bystanders, and it is the single most common reason CPR is delayed.

The family member watching this event experiences acute psychological trauma. Studies of family members present during resuscitation document high rates of post-traumatic stress disorder (PTSD) in the weeks and months after the event 5 / Solid . The Jabre trial found that family presence during resuscitation, when guided by a trained team member, was actually associated with lower PTSD symptoms, not higher. This is a finding that should influence hospital and EMS policy.

What the Survivor Faces

Survivors of out-of-hospital cardiac arrest face a recovery that television never depicts. The early phase involves ICU admission, often intubation and mechanical ventilation, targeted temperature management or fever avoidance protocols, and neurological prognostication. For patients with good neurological recovery, the subsequent weeks involve physical rehabilitation, fatigue, cognitive fog (“post-arrest cognitive syndrome”), and the psychological weight of having died and been brought back.

Most survivors who receive an ICD (as the majority should) describe a complex relationship with the device. Some report significant anxiety about receiving a shock. Some describe hypervigilance about physical symptoms. The transition from “cardiac arrest survivor” to “person living with heart disease” requires support that goes beyond device implantation.

The Family Member Who Is Never Trained

The single most modifiable predictor of cardiac arrest survival is bystander CPR. The single most common bystander at an out-of-hospital cardiac arrest is a family member. The training gap is therefore not a stranger problem. It is a family problem.

In a 2019 survey analysis, fewer than 20 percent of adults living with someone who had established heart disease reported CPR training in the prior two years 4 / Promising . That is the family member who stood over the patient for four minutes waiting for the ambulance.

This is fixable. The investment is ninety minutes at a community CPR class, or thirty minutes with a Hands-Only CPR video from the AHA. The return is a meaningful probability of saving a life.

Decisions and Trade-Offs

The ICD Question: Who Gets a Device?

The decision to implant an ICD is, in the out-of-hospital cardiac arrest survivor, usually straightforward: implant the device. Secondary prevention ICD therapy in survivors of VFib/VT arrest reduces recurrent sudden death risk by approximately 30 to 40 percent compared to antiarrhythmic drugs 5 / Solid .

The more nuanced question is primary prevention: who implants an ICD before the first arrest? The threshold is currently defined as ejection fraction below 35 percent on maximally tolerated medical therapy, with NYHA Class II-III symptoms, and predicted survival >1 year (2022 AHA/ACC/HRS Ventricular Arrhythmia Guidelines). SCD-HeFT established this threshold for non-ischemic and ischemic cardiomyopathy alike.

What the guideline does not address is the patient with an EF of 40 to 49 percent, or the patient with a high coronary artery calcium score and preserved EF, or the asymptomatic patient with a genetic channelopathy. These decisions are made in consultation with electrophysiology, not through a formula.

Resuscitation Status: The Conversation That Happens Too Late

In the United States, fewer than 30 percent of adults have completed an advance directive 4 / Promising . That means the vast majority of patients who arrest in the hospital or arrive by EMS have no documented preferences. Families are asked, in the middle of a crisis, to make decisions they were never prepared to make.

The clinical position is explicit: every adult over 50 should have a documented resuscitation preference, and that preference should be revisited after every major cardiac diagnosis. This is not about encouraging patients to decline CPR. It is about ensuring that when a decision is made, it reflects the patient’s actual values, not the default of “do everything” that often leads to futile resuscitation in patients for whom aggressive CPR would not align with their wishes.

The Rural Patient’s Calculus

For a patient living thirty minutes from the nearest AED and forty-five minutes from the nearest hospital, the calculus is different. Survival to hospital discharge for unwitnessed OHCA in rural settings with prolonged EMS response is below 2 percent 4 / Promising . This patient’s best survival strategy is preventing the arrest, not surviving it.

Primary prevention: treating the CAD, managing the ejection fraction, checking the QT interval on medications, catching the inherited channelopathy in the offspring before it presents as sudden death. This is where a structured cardiovascular assessment and structured remote monitoring function as prevention infrastructure.

Clinical Synthesis

Cardiac arrest is the terminal event that most preventable cardiovascular death becomes. The clinical infrastructure around cardiac arrest survival is excellent in some ZIP codes and nearly absent in others. This program addresses this asymmetry at three levels.

Level 1, Awareness and immediate-response preparation. The A free cardiac emergency resource that includes a one-page cardiac arrest response guide, a CPR quick-reference card, and the five questions every adult should ask their physician each year. Available at the platform. This is not a physician product. It is a community product. A family member, a neighbor, a coworker who knows how to activate the chain of survival is worth more than any device to the patient who arrests in a non-clinical setting.

Level 2, Risk identification before the first event. a structured cardiovascular assessment is the annual cardiovascular risk assessment built for people who have never had a cardiac event and want to understand their actual risk rather than their estimated risk. Coronary artery calcium scoring, genetic screening for inherited channelopathies where family history warrants it, medication review for QT-prolonging drugs, and ejection fraction assessment for patients with unexplained symptoms. The arrest that does not happen is the only arrest that is 100 percent survivable.

Level 3, Post-event recovery and follow-through. For patients who have survived a cardiac arrest and been discharged, structured remote monitoring provides longitudinal tracking, ICD monitoring coordination, and the structured support that the transition from ICU to outpatient care typically lacks. The post-arrest cognitive and psychological sequelae are predictable; they should not be discovered by the patient alone at home.

Carle Foundation Hospital in Urbana provides in-region resuscitation follow-up. Northwestern Medicine in Chicago maintains a dedicated cardiac arrest survivor program. For patients in rural central Illinois or western Indiana, referral pathways to Peoria’s OSF Saint Francis Medical Center or Springfield’s HSHS St. John’s Hospital are available through the clinical network.

The cardiologist standing at the bedside of a cardiac arrest survivor asks: did this have to happen? In most cases, the answer is yes, it happened, because the risk was invisible and the system did not catch it. This program is built to make that invisibility less common.

The next article in this lane, CPR and the AED, covers what to do in the first minutes. Read that one before someone in your household needs you to know it.

Racial and Geographic Disparities in Cardiac Arrest Outcomes

The national average survival rate of 10 percent conceals a wide disparity. Black Americans with OHCA have substantially lower survival rates than white Americans, even after controlling for presenting rhythm, bystander CPR rates, and EMS response time 5 / Solid . This disparity is partly explained by lower bystander CPR rates in predominantly Black neighborhoods, lower AED density in those neighborhoods, and longer EMS response times in underserved urban cores.

A 2021 analysis of the CARES registry stratified by ZIP code found that bystander CPR rates ranged from 23 percent in low-income predominantly Black neighborhoods to 55 percent in high-income predominantly white neighborhoods 5 / Solid . AED density followed the same gradient. This is not a random distribution; it reflects decades of differential investment in public safety infrastructure.

The geographic disparity is equally stark. Rural counties in Illinois, Indiana, Kentucky, and across the South have median EMS response times above eight minutes, outside the window where defibrillation is most effective. Urban areas with tiered response systems and co-responder programs (police AED programs) achieve substantially shorter times 4 / Promising .

Correcting these disparities requires structural changes: public access AED programs targeted to underserved neighborhoods, community CPR training in churches and schools rather than only in workplaces, and EMS funding models that support rural response capability. This program cannot solve structural underinvestment, but this educational resource is deliberately free and designed for community distribution, not just direct-to-patient deployment.

The Genetics of Sudden Cardiac Death Risk

For a subset of cardiac arrest patients, the risk was encoded in their DNA from birth. Inherited channelopathies and cardiomyopathies account for a meaningful fraction of SCA in patients under 40 and create a specific clinical obligation: identifying at-risk family members before the first event.

Long QT syndrome (LQTS): Mutations in cardiac ion channel genes (KCNQ1, KCNH2, SCN5A, and others) prolong the QT interval and predispose to Torsades de Pointes, a polymorphic ventricular tachycardia that can degenerate into VFib. Prevalence approximately 1 in 2,000. Autosomal dominant in most forms. First-degree relatives of an LQTS patient have a 50 percent probability of carrying the mutation and should be screened 5 / Solid . Treatment: beta-blockers, avoidance of QT-prolonging medications, ICD for high-risk patients.

Brugada syndrome: SCN5A mutations producing a characteristic coved ST elevation in V1-V3 on ECG. Predominantly affects men in their thirties and forties. SCA risk is highest during sleep or fever. First-line treatment for high-risk patients: ICD 5 / Solid .

Catecholaminergic polymorphic ventricular tachycardia (CPVT): RYR2 mutations causing calcium-handling abnormalities that produce ventricular arrhythmias during exercise or emotional stress. Exercise stress testing reveals bidirectional VT as the signature finding. Beta-blocker therapy reduces events. ICD implantation required for breakthrough events on therapy 5 / Solid .

Hypertrophic cardiomyopathy (HCM): MYH7, MYBPC3, and other sarcomere gene mutations produce asymmetric LV hypertrophy, dynamic outflow obstruction, and diastolic dysfunction. The most common cause of SCA in young competitive athletes in the US. Risk stratification for ICD uses the AHA/ACC HCM risk calculator incorporating family history of SCD, prior syncope, LVOT gradient, LV wall thickness, and LV outflow tract morphology 5 / Solid 00416-8).

For individuals with a family history of unexplained sudden death, particularly in young family members, genetic testing and cardiovascular evaluation is a clinical priority. A structured cardiovascular assessment workflow includes a structured family history screen specifically designed to identify pedigrees at risk for inherited channelopathies and cardiomyopathies.

Prevention as the Primary Cardiac Arrest Strategy

The honest assessment of current cardiac arrest survival technology is this: once a patient is in cardiac arrest, the best possible system outcomes are still 10 to 40 percent survival, and a significant fraction of survivors carry neurological or psychological sequelae. Prevention is not a consolation prize for failed resuscitation. It is the strategy with the highest absolute benefit.

Preventable cardiac arrest falls into three categories:

Primary prevention through risk factor control: Treating hypertension, hyperlipidemia, diabetes, and tobacco use reduces both the incidence of coronary artery disease-triggered VFib and the development of cardiomyopathy that creates the substrate for late arrhythmias. The evidence base for each intervention is covered throughout the library.

Primary prevention through device therapy: ICD implantation in patients with EF below 35 percent (the SCD-HeFT population) prevents approximately 7 to 10 sudden deaths per 100 patient-years 5 / Solid . Subcutaneous ICD (Boston Scientific S-ICD, FDA-cleared PMA) avoids transvenous leads and is appropriate for patients without pacing indications who are at SCD risk but do not need anti-tachycardia pacing 4 / Promising .

Secondary prevention through post-event evaluation: Every cardiac arrest survivor needs a complete evaluation of the precipitating cause. The evaluation protocol includes: coronary angiography (in relevant patients), electrophysiology study (in selected patients), genetic evaluation (in arrests without obvious structural cause, particularly in young patients), and cardiac MRI (for fibrosis quantification in cardiomyopathy patients). Missing the precipitating cause in a survivor is a setup for recurrent arrest.

This program is built around the conviction that the most impactful intervention in cardiac arrest medicine is the one that happens years before the event: the Audit that identifies the silent CAD, the genetic screen that finds the LQTS in the asymptomatic family member, the medication review that catches the QT-prolonging drug before it triggers Torsades in the patient with unrecognized baseline QT prolongation.

That arrest in the university cafeteria should not have been the administrator’s introduction to his cardiac risk. It was, because no one had run the CAC score or checked the resting ECG that might have shown a subtle abnormality. That is the preventable version of this story. This system is built to find it before the cafeteria.

Risk Stratification Before the Event: The Architecture of Prevention

Cardiac arrest prevention depends on identifying who is at risk before the event occurs. This is not a simple problem: the majority of sudden cardiac deaths occur in people without previously diagnosed heart disease 5 / Solid . The event is the diagnosis, not the conclusion of a clinical workup.

This epidemiological reality creates the prevention paradox: the most impactful interventions for cardiac arrest prevention must reach people who feel well, whose physicians have not flagged them as high-risk, and who have no compelling reason to pursue cardiac evaluation. This clinical framework is designed precisely for this population.

Coronary Artery Disease as the Dominant Substrate

Approximately 80 percent of sudden cardiac deaths in adults over 40 occur in patients with underlying coronary artery disease 5 / Solid . In many of these patients, the CAD was not clinically recognized before the event. It was present on coronary angiography or autopsy as significant atherosclerotic stenosis, but no clinical evaluation had been performed.

The coronary artery calcium (CAC) score is the most evidence-based tool for asymptomatic CAD detection in intermediate-risk individuals. The MESA (Multi-Ethnic Study of Atherosclerosis) trial enrolled 6,814 adults free of cardiovascular disease and showed that CAC score zero conferred a very low 10-year CVD event rate (below 5%), while CAC scores above 400 were associated with annual CVD event rates exceeding 3 percent 5 / Solid . The CAC score reclassifies risk in approximately 40 to 50 percent of individuals categorized as intermediate-risk by the Pooled Cohort Equations.

For a 52-year-old male with borderline hypertension, a 10-pack-year smoking history, a total cholesterol of 215 mg/dL, and no symptoms, the Pooled Cohort Equation 10-year ASCVD risk is approximately 10 to 12 percent. The CAC score tells you whether that 10 percent risk is distributed across calcified coronary plaques that have been accumulating for decades or whether the 10 percent is based on statistical population averages in a person who has, in fact, no calcified plaque. These are very different biological realities that should produce very different management conversations.

A CAC score of 0 in this patient reclassifies his risk downward and allows shared decision-making about whether statin therapy is necessary at this time. A CAC score of 650 reclassifies his risk upward, provides direct evidence of an established atherosclerotic plaque burden, and supports high-intensity statin therapy, aspirin if appropriate, and a stress test or CT coronary angiogram to define the hemodynamic significance of the plaque.

The ECG as a Baseline Cardiovascular Fingerprint

A resting 12-lead ECG is available for under $50 in most outpatient settings and provides a baseline document with diagnostic implications that extend across decades of care. For a 45-year-old with no cardiac history, a resting ECG today serves as the reference against which any future ECG can be compared. An ST-segment change, new T-wave inversion, or bundle branch block found at age 55 is meaningfully interpreted only against the 45-year-old baseline.

The ECG also identifies several conditions directly relevant to sudden cardiac death risk that are entirely asymptomatic:

• QTc prolongation (QTc above 480 ms in women, above 460 ms in men): identifies patients at risk for Torsades de Pointes, particularly with QT-prolonging medications
• Wolff-Parkinson-White pattern (delta wave, short PR): identifies a pathway for rapid pre-excited AF and ventricular fibrillation in rare cases
• Brugada pattern (coved Type 1 pattern in V1-V2): identifies patients at risk for VF in the absence of structural disease
• Evidence of prior MI (Q waves): identifies patients with prior myocardial infarction who may have scar substrate for ventricular tachycardia

None of these findings are identified by blood pressure measurement, cholesterol testing, or history-taking alone. They require an ECG. The routine ECG in a middle-aged adult is a one-time low-cost intervention with potentially decades of diagnostic utility.

Hypertrophic Cardiomyopathy: Genetic Testing and Family Screening

HCM is the leading identifiable cause of sudden cardiac death in young athletes 5 / Solid . Its prevalence of 1 in 500 adults means that in a primary care panel of 1,000 patients, approximately 2 patients have HCM. Some of those patients are known to their cardiologist. Others are not.

The SCD risk stratification model for HCM has evolved significantly. The original 2003 Bethesda Conference criteria for SCD risk included a list of major and minor risk factors (massive LV hypertrophy, family history of SCD, unexplained syncope, NSVT on Holter, abnormal BP response to exercise). The 2014 ESC HCM SCD risk calculator expanded this to a continuous risk score incorporating age, maximal LV wall thickness, LA diameter, LVOT gradient, family history of SCD, NSVT, and unexplained syncope 5 / Solid .

The American HCM Society guidelines recommend genetic testing for probands with HCM and cascade screening for first-degree relatives 5 / Solid . For the family member who tests positive for a pathogenic HCM mutation but has no clinical HCM on echocardiography, the recommendation is clinical surveillance with echocardiography every 1 to 3 years and an ECG, without ICD implantation in the absence of clinical disease or major risk factors.

A structured cardiovascular assessment framework applied to a patient diagnosed with HCM generates an immediate family screening checklist. The proband’s three adult siblings, two college-age children, and parents are each identified as needing clinical evaluation (history, physical examination, ECG, echocardiography) and genetic counseling. This is not complex clinical work. It requires sending three letters and making two phone calls. The system that ensures it happens ( rather than leaving it to the proband to remember to tell their relatives ) is the difference between proactive prevention and reactive crisis management.

Channelopathies and the Invisible Electrical Substrate

Not all sudden cardiac deaths occur in hearts with structural disease. Channelopathies ( inherited disorders of ion channels producing arrhythmia without structural cardiac abnormality ) account for approximately 10 to 15 percent of sudden unexplained cardiac deaths in young people 5 / Solid .

The clinically recognized channelopathies include:

Long QT Syndrome (LQTS): Autosomal dominant inheritance in most forms (LQT1, LQT2, LQT3 being the most common). Mutations in KCNQ1, KCNH2, and SCN5A account for over 75 percent of genotype-positive LQTS. The risk is triggered by specific stimuli: LQT1 events cluster during exercise or swimming, LQT2 events during auditory stimuli (alarm clocks, telephones), LQT3 events during sleep or bradycardia. Identification allows both trigger avoidance and pharmacological therapy (beta-blockers for LQT1/2) or class IB therapy (mexiletine for LQT3).

Brugada Syndrome: SCN5A mutations in approximately 20 to 30 percent of cases. Type 1 Brugada pattern is associated with VF events, most commonly at night during fever or bradycardia. Fever is an important trigger: Brugada syndrome patients should receive antipyretics early in febrile illness and should carry a Brugada warning card for emergency department visits. The ICD is the only intervention with demonstrated efficacy for high-risk Brugada 5 / Solid .

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT): RYR2 mutations. Exercise-triggered bidirectional or polymorphic VT in structurally normal hearts. Beta-blockade reduces but does not eliminate events. Flecainide has shown additive benefit in reducing VT burden 4 / Promising .

The key clinical point: every unexplained syncope in a young person, and every unexplained death in a person under 50 with an otherwise normal autopsy, warrants evaluation for a channelopathy. A family history of unexplained sudden death, drowning, or single-car accidents in healthy young individuals should trigger a clinical evaluation protocol including ECG, exercise stress test, epinephrine or ajmaline provocation testing where appropriate, and genetic counseling.

Post-Arrest Outcomes by Arrest Setting and Witnessed Status

The outcome from cardiac arrest is profoundly influenced by where the arrest occurs and whether it is witnessed. These factors are not random, they reflect the intersection of geography, health system access, and socioeconomic determinants that drive health outcomes throughout cardiovascular medicine.

In-Hospital vs. Out-of-Hospital Cardiac Arrest

In-hospital cardiac arrest (IHCA) occurs in a monitored or semi-monitored environment with immediate access to defibrillators, resuscitation equipment, and trained personnel. Despite this advantage, survival to discharge after IHCA is approximately 25 to 30 percent 5 / Solid . The survival rate for IHCA has improved over the past two decades, from approximately 13 percent in 2000 to 25 to 30 percent currently, reflecting improvements in post-ROSC care, targeted temperature management protocols, and system-level quality improvement.

OHCA is a different clinical reality. Without bystander CPR, without a nearby AED, without rapid EMS response, the survival rate falls to below 5 percent for most jurisdictions 5 / Solid . With all elements of the Chain of Survival in place ( bystander CPR, AED use within 3 to 5 minutes, EMS arrival within 8 minutes ) survival rates for VFib-initiated OHCA at 35 to 50 percent are achievable.

The rural-urban disparity in OHCA outcomes is one of the starkest in cardiovascular medicine. Rural EMS response times average 14 minutes versus 6 minutes in urban areas 5 / Solid . Each minute without defibrillation reduces VFib survival by approximately 7 to 10 percent. In rural Illinois ( Kankakee, Decatur, and smaller communities outside the Chicago metro area ) the EMS response time gap translates directly into survival gap. A patient in cardiac arrest at a Champaign restaurant has different odds than the same patient in cardiac arrest at a farm in Douglas County, even if the underlying rhythm is identical.

Witnessed vs. Unwitnessed Arrest

Witnessed arrest is the strongest independent predictor of survival in OHCA. Witnessed arrest occurs in approximately 40 percent of OHCA cases 5 / Solid . The mechanism is simple: an observed patient can receive CPR within seconds of collapse. An unwitnessed arrest may lie undetected for minutes or hours, by which time the window for neurologically intact survival has closed.

The corollary is that the highest-impact intervention for OHCA survival is bystander CPR training. Communities with higher rates of bystander CPR training ( Scandinavian countries, Japan, parts of the Pacific Northwest ) demonstrate survival rates for OHCA that substantially exceed U.S. national averages 5 / Solid . The Seattle-King County EMS system, a benchmark program in the U.S., achieves survival rates for VFib OHCA of 40 to 45 percent through high bystander CPR rates, high public AED density, and rapid EMS response.

The implication for the individual is direct: every adult who knows CPR represents a potential chain of survival link for someone in their household, their workplace, their neighborhood. The CPR-trained spouse of a high-risk cardiac patient is a clinical intervention. Teaching her CPR at the intake visit is not optional, it is part of the preventive care plan.

Cardiac Arrest in Special Populations: Women, Athletes, and the Elderly

Women and Cardiac Arrest

Women have lower rates of OHCA than men across all age groups, but the biology and outcomes are not simply “men’s disease in women.” When women experience cardiac arrest, their presentations differ and their outcomes are sometimes worse, in part because of system-level disparities in response and management.

Women are less likely to receive bystander CPR than men (65.7% vs. 67.5% in public locations, 37.4% vs. 42.7% in residential locations in large registry data) 5 / Solid . The disparity in residential CPR rates likely reflects hesitancy about touching a female victim’s chest that is not present for male victims. This is a teachable, addressable behavioral pattern.

Women with cardiac arrest have a lower prevalence of VFib as the initial rhythm (approximately 24% in women vs. 36% in men) 5 / Solid . Since VFib is the most shockable and most survivable rhythm, the lower VFib prevalence in women partly explains their lower arrest-to-survival conversion rate. The higher prevalence of PEA and asystole in women reflects different underlying arrest etiologies: less ischemic and more structural (cardiomyopathy, arrhythmic) substrates in women.

The LQTS sex interaction is clinically important: women have naturally longer QTc intervals than men, and women with LQTS have a higher risk of life-threatening arrhythmias at puberty, particularly during the postpartum period when progesterone falls and QTc lengthens 5 / Solid . The post-partum period carries the highest risk of LQTS-related events in affected women. A woman with a family history of LQTS or unexplained syncope who presents in the post-partum period should have an ECG as part of her routine post-delivery workup.

Athletes and Exercise-Related Cardiac Arrest

The absolute risk of cardiac arrest during exercise is low, approximately 1 in 18,000 per year in adult competitive athletes 5 / Solid . But the relative risk is raised during and immediately after exercise compared to rest, reflecting the catecholamine surge, increased myocardial oxygen demand, and arrhythmia triggers associated with intense physical exertion.

The Illinois High School Association (IHSA) requires a pre-participation physical examination for all student athletes, aligned with the AHA’s 14-element cardiac history and examination checklist. Athletes with positive history elements (personal history of exertional chest pain, syncope with exertion, unexplained heart murmur, family history of premature SCD below age 50) are referred for further evaluation before clearance.

The framework on cardiac arrest is not about reducing exercise. It is about identifying the structural or electrical substrate that converts exercise from a health benefit into an arrhythmia trigger. For the vast majority of athletes, exercise is protective. The athlete who asks “should I stop running?” after reading about exercise-related cardiac arrest should be reassured that the absolute risk is low, and the population-level mortality from inactivity vastly exceeds the population-level mortality from exercise-triggered cardiac arrest in structurally normal hearts 5 / Solid .

The Elderly Patient and Resuscitation Goals

Among adults 75 and older, in-hospital cardiac arrest survival to discharge is approximately 15 to 18 percent, compared to 30 percent in younger adults 5 / Solid . The lower survival reflects higher pre-arrest comorbidity, reduced physiological reserve, and the higher prevalence of non-shockable rhythms in older adults.

The appropriate response to these survival statistics is not therapeutic nihilism about elderly cardiac arrest victims. It is honest, prospective conversation about goals of care before an arrest occurs. The 78-year-old with metastatic cancer, severe dementia, or end-stage COPD who has not had a goals-of-care conversation is not well-served by aggressive CPR following an arrest. The 78-year-old who is cognitively intact, lives independently, and whose cardiac arrest results from a reversible cause (VFib from a correctable ischemic substrate) may achieve excellent outcomes with resuscitation.

The difference between these two patients is not age. It is the clinical context, the patient’s values, and whether those values have been documented before the emergency. A cardiologist-led preventive program specifically includes advance care planning documentation as a deliverable: a written POLST form, a completed advance directive, and a designated healthcare power of attorney. These are not forms for dying. They are documents for living, they ensure that the clinical system responds to a future emergency in alignment with the patient’s actual preferences rather than the default protocol.

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.